Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 18 October, 2012 and appeared in  Issue 648

Sleepless Nights Increase Risk for Diabetes

Sleep deprivation can affect insulin resistance....
Advertisement

According to a small new study that looks at how fat cells respond to sleepless nights, poor sleep may not only leave you drowsy, it might also raise your odds for a precursor condition to diabetes.

Matthew Brady, senior study author and an associate professor of medicine at the University of Chicago Medical Center, stated that, "It's always been thought that the primary function of sleep was for the brain, but in addition to the brain, your fat cells also need sleep." "Too little sleep makes you groggy, and the same thing happens on a metabolic level." "Cells don't behave as they normally would, and this can lead to insulin resistance."

Other recent research has suggested that a lack of sleep can lead to a variety of problems, such as insulin resistance, obesity, type 2 diabetes, heart disease, stroke and high blood pressure, according to background information in the study. What hasn't been clear, though, is why too little shuteye is linked to these conditions.

"This is the first time that sleep has been studied at the cellular level," Brady explained.

For the current study, the researchers recruited seven healthy, normal-weight young adults whose average age was just under 24 years.

The study volunteers were randomly assigned to spend four nights simulating sufficient sleep by sleeping 8.5 hours and four nights simulating sleep deprivation by sleeping just 4.5 hours a night. The four-night stretches of sleep simulations were spaced four weeks apart. The study took place in a sleep lab.

After each four-day simulation, the researchers measured how well each person processed glucose (sugar), and they took samples of fat cells from each person's abdomen.

The investigators found that in people who were sleep deprived, the fat cells' ability to respond to insulin was reduced by 30 percent. And, insulin levels were almost three times higher than in the well-rested study participants. High insulin levels tend to indicate that something isn't working properly in the metabolic system, and insulin resistance is occurring. To try to compensate, the pancreas makes more insulin. If this cycle continues for too long, type 2 diabetes can develop.

"Sleep is incredibly important, not only for cognitive [brain] function, but also for your metabolic health as well," Brady said.

The researchers are currently recruiting for a trial of overweight people with sleep apnea to see if treating the sleep apnea has an effect on the body's metabolism.

Dr. Shelby Freedman Harris, director of the behavioral sleep medicine program at the Sleep-Wake Disorders Center at Montefiore Medical Center in New York City, said this was an interesting study that sheds light on how a lack of sleep can contribute to the metabolic syndrome. Metabolic syndrome is the name given to a cluster of risk factors that together increase the risk of heart disease, stroke and type 2 diabetes.

"If you're not sleeping enough, you need to know that it's impacting you on a cellular level," she said. And, if you're already overweight, a lack of sleep can put you at risk of further complications, such as sleep apnea, which in turn, leads to less sleep.

"A lack of sleep can really set up a vicious cycle. Sleep should be considered as important as diet when you're trying to prevent weight gain and diabetes. Just because society isn't sleeping as much as necessary doesn't mean you shouldn't try," Harris added.

While the study found an association between reduced sleep and insulin resistance, it did not prove a cause-and-effect relationship.

Matthew Brady, Ph.D., associate professor, medicine, University of Chicago Medical Center; Spyros Mezitis, M.D., endocrinologist and clinical investigator, Lenox Hill Hospital, New York City; Shelby Freedman Harris, Psy.D., director, behavioral sleep medicine, Sleep-Wake Disorders Center, Montefiore Medical Center, New York City; Oct. 16, 2012, Annals of Internal Medicine 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 18 October, 2012 and appeared in  Issue 648

Past five issues: Diabetes Clinical Mastery Series Issue 203 | Issue 743 | Diabetes Clinical Mastery Series Issue 202 | SGLT-2 Inhibitors Special Edition August 2014 | GLP-1 Special Editions August 2014 |

2014 Most Popular Articles:

Low-carb Diet Recommended for Type 1 and 2 Diabetes Patients
Posted August 01, 2014
New Combination of Diabetes Drugs Have Synergistic Effect
Posted August 08, 2014
New Encapsulated Beta-Cell Replacement Therapy for Type 1 Diabetes
Posted August 08, 2014
FDA Approves J&J's Invokamet Combo (SGLT-2 + Metformin)
Posted August 15, 2014
During Prolonged Low-Intensity Exercise, Caffeine Alters Blood Glucose
Posted August 15, 2014
HbA1c Increases with Age
Posted August 01, 2014
Diabetic Neuropathy Improved with Vegan Diet
Posted August 22, 2014
SGLT2 Inhibitor Empagliflozin Wins FDA OK
Posted August 08, 2014
New Way to Regenerate Beta Cells in Type 1 Diabetes Patients
Posted August 08, 2014
CDC: 40% of American Adults Will Develop Diabetes
Posted August 22, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Do you recommend SGLT-2 drugs for type 1 diabetes?
CME/CE of the Week
Deepak Bhatt, MD, MPH, and Jeffrey J. Popma, MD

Category: Cardiology
Credits:
 1
Search Articles On Diabetes In Control